Original Article
Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies
Tofacitinib, un inhibidor oral de la cinasa Janus, en pacientes Mexicanos con Artritis Reumatoide: análisis de eficacia y seguridad de estudios fase 3 y de extensión a largo plazo
Ruben Burgos-Vargasa, Mario Cardielb, Daniel Xibillèc)c, Cèc)sar Pacheco-Tenad, Virginia Pascual-Ramose, Carlos Abud-Mendozaf, Ehab Mahgoubg, Mahboob Rahmanh,⭊, Haiyun Fani, Ricardo Rojoi, Erika Garcíag,⭊, Karina Santanaj,
Corresponding author
a Hospital General de Mèc)xico, Ciudad de Mèc)xico, Mexico
b Centro de Investigación Clínica de Morelia, Morelia, Mexico
c Servicios de Salud de Morelos, Morelos, Mexico
d Universidad Autónoma de Chihuahua, Chihuahua, Mexico
e Instituto Nacional de Ciencias, Ciudad de Mèc)xico, Mexico
f Hospital Central, San Luis Potosí, Mexico
g Pfizer Inc., Collegeville, PA, USA
j Pfizer Inc., Ciudad de Mèc)xico, Mexico
Ver másRead
4277
Timeswas read the article
1782
Total PDF
2495
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 7 | 0 | 8 | 8 |
| 2025 6 | 2 | 19 | 21 |
| 2025 5 | 110 | 54 | 164 |
| 2025 4 | 89 | 21 | 110 |
| 2025 3 | 62 | 33 | 95 |
| 2025 2 | 42 | 33 | 75 |
| 2025 1 | 43 | 59 | 102 |
| 2024 12 | 41 | 28 | 69 |
| 2024 11 | 44 | 48 | 92 |
| 2024 10 | 31 | 20 | 51 |
| 2024 9 | 29 | 20 | 49 |
| 2024 8 | 43 | 29 | 72 |
| 2024 7 | 40 | 24 | 64 |
| 2024 6 | 46 | 27 | 73 |
| 2024 5 | 46 | 23 | 69 |
| 2024 4 | 34 | 18 | 52 |
| 2024 3 | 31 | 24 | 55 |
| 2024 2 | 35 | 18 | 53 |
| 2024 1 | 36 | 16 | 52 |
| 2023 12 | 12 | 30 | 42 |
| 2023 11 | 33 | 30 | 63 |
| 2023 10 | 30 | 24 | 54 |
| 2023 9 | 141 | 45 | 186 |
| 2023 8 | 27 | 15 | 42 |
| 2023 7 | 24 | 19 | 43 |
| 2023 6 | 25 | 16 | 41 |
| 2023 5 | 41 | 23 | 64 |
| 2023 4 | 23 | 17 | 40 |
| 2023 3 | 60 | 23 | 83 |
| 2023 2 | 43 | 22 | 65 |
| 2023 1 | 39 | 11 | 50 |
| 2022 12 | 62 | 26 | 88 |
| 2022 11 | 43 | 29 | 72 |
| 2022 10 | 59 | 34 | 93 |
| 2022 9 | 30 | 22 | 52 |
| 2022 8 | 30 | 33 | 63 |
| 2022 7 | 30 | 40 | 70 |
| 2022 6 | 30 | 33 | 63 |
| 2022 5 | 31 | 28 | 59 |
| 2022 4 | 37 | 33 | 70 |
| 2022 3 | 34 | 52 | 86 |
| 2022 2 | 38 | 33 | 71 |
| 2022 1 | 49 | 33 | 82 |
| 2021 12 | 34 | 30 | 64 |
| 2021 11 | 45 | 36 | 81 |
| 2021 10 | 41 | 49 | 90 |
| 2021 9 | 30 | 37 | 67 |
| 2021 8 | 34 | 36 | 70 |
| 2021 7 | 23 | 18 | 41 |
| 2021 6 | 25 | 21 | 46 |
| 2021 5 | 37 | 41 | 78 |
| 2021 4 | 85 | 122 | 207 |
| 2021 3 | 52 | 22 | 74 |
| 2021 2 | 25 | 18 | 43 |
| 2021 1 | 31 | 25 | 56 |
| 2020 12 | 24 | 13 | 37 |
| 2020 11 | 27 | 15 | 42 |
| 2020 10 | 24 | 16 | 40 |
| 2020 9 | 25 | 16 | 41 |
| 2020 8 | 23 | 20 | 43 |
| 2020 7 | 26 | 17 | 43 |
| 2020 6 | 37 | 9 | 46 |
| 2020 5 | 33 | 15 | 48 |
| 2020 4 | 28 | 9 | 37 |
| 2020 3 | 11 | 2 | 13 |
| 2019 6 | 0 | 2 | 2 |
Show all
